5978-08-5

Basic information

• Product Name: 5-CHLORO-2-PENTANONE ETHYLENE KETAL
• Synonyms: 2-(3-CHLOROPROPYL)-2-METHYL-1,3-DIOXOLANE;5-CHLORO-2-PENTANONE ETHYLENE KETAL;2,2-(Ethylenedioxy)-5-chloropentane;2-(3-CHLOROPROPYL)-2-METHYL-1 3- &;1,3-Dioxolane, 2-(3-chloropropyl)-2-methyl-;4,4-(Ethylenedioxy)pentyl chloride.;5-CHLORO-2-PENTANONE ETHYLENE KETAL 97%;2-Methyl-(3-chloropropyl)-1,3-dioxolane
• CAS NO: 5978-08-5
• Molecular Formula: C₇H₁₃ClO₂
• Molecular Weight: 164.63
• EINECS: 227-776-5
• Mol File: 5978-08-5.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 73-76 °C7 mm Hg(lit.)
• Flash Point: 163 °F
• Appearance: Clear colorless to light yellow/Liquid
• Density: 1.094 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.387mmHg at 25°C
• Refractive Index: n20/D 1.449(lit.)
• BRN: 104617
• CAS DataBase Reference: 5-CHLORO-2-PENTANONE ETHYLENE KETAL(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-2-PENTANONE ETHYLENE KETAL(5978-08-5)
• EPA Substance Registry System: 5-CHLORO-2-PENTANONE ETHYLENE KETAL(5978-08-5)

Safety Data

• Safety Statements: 23-24/25
• WGK Germany: 3
• F: 21
• Hazardous Substances Data: 5978-08-5(Hazardous Substances Data)

Usage

Description

5-CHLORO-2-PENTANONE ETHYLENE KETAL is a clear, colorless to light yellow liquid that is a derivative of 2-pentanone with a chloro and ethylene ketal functional group. It is a synthetic compound with potential applications in various industries due to its unique chemical properties.

Uses

Used in Pharmaceutical Industry:
5-CHLORO-2-PENTANONE ETHYLENE KETAL is used as an intermediate compound for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs, particularly those targeting specific biological pathways.
Used in Chemical Synthesis:
In the chemical industry, 5-CHLORO-2-PENTANONE ETHYLENE KETAL serves as a versatile building block for the synthesis of a wide range of organic compounds. Its reactivity and functional groups make it a valuable asset in creating new molecules with specific properties and applications.
Used in Research and Development:
Due to its unique chemical structure, 5-CHLORO-2-PENTANONE ETHYLENE KETAL is used in research and development for exploring new reactions and understanding the behavior of similar compounds. It can provide insights into the synthesis of novel molecules and contribute to the advancement of chemical knowledge.
Used in Material Science:
5-CHLORO-2-PENTANONE ETHYLENE KETAL's properties may also make it suitable for use in the development of new materials with specific characteristics, such as improved stability, reactivity, or selectivity. It could be employed in the creation of advanced materials for various applications, including coatings, adhesives, or polymers.
Used in Preparation of Specific Compounds:
As mentioned in the provided materials, 5-CHLORO-2-PENTANONE ETHYLENE KETAL was used in the preparation of 7-[(4,4-Ethylenedioxy)pentoxy]-2H-1-benzopyran-2-one, indicating its potential use in the synthesis of specific target compounds with desired properties.

InChI:InChI=1/C7H13ClO2/c1-7(3-2-4-8)9-5-6-10-7/h2-6H2,1H3

Upstream product

• 5891-21-4 5-chloro-2-pentanone 
• 107-21-1 ethylene glycol 
• 29021-98-5 3-(2-methyl-[1,3]dioxolan-2-yl)-propan-1-ol 

Downstream Products

• 10412-98-3 5-oxohexanenitrile 
• 6303-82-8 1-phenylhexane-1,5-dione 
• 97023-74-0 1-(4-methylphenyl)-hexane-1,5-dione 
• 3128-06-1 5-ketohexanoic acid 
• 67808-83-7 4,4,5,5-tetramethyl-2-[4-(2-methyl-[1,3]dioxolan-2-yl)-1-phenylsulfanyl-butyl]-[1,3,2]dioxaborolane 
• 66080-33-9 4,4,5,5-tetramethyl-2-[1-methyl-4-(2-methyl-[1,3]dioxolan-2-yl)-1-phenylsulfanyl-butyl]-[1,3,2]dioxaborolane 
• 80376-43-8 5-cyclohex-1-enyl-pentan-2-one 
• 58568-20-0 1-[3-(2-methyl-[1,3]dioxolan-2-yl)-propyl]-cyclohexanol 
• 58568-17-5 2-(4-hydroxy-4-phenylbutyl)-2-methyl-1,3-dioxolane 
• 72693-12-0 6-hydroxyheptan-2-one 
• 689-39-4 6,8-dimethyl-non-5-en-2-one 
• 689-66-7 6,10-dimethyl-undec-5-en-2-one 
• 24199-46-0 6-methyl-5-octen-2-one 
• 928-39-2 hept-6-yn-2-one 

Relevant articles and documents

-

-

Deuterated hydroxychloroquine derivative and pharmaceutical composition containing deuterated hydroxychloroquine derivative

The invention relates to a deuterated hydroxychloroquine derivative and a pharmaceutical composition containing the deuterated hydroxychloroquine derivative. Specifically, the invention discloses a deuterated hydroxychloroquine derivative shown as a formula (I) and a pharmaceutical composition containing the deuterated hydroxychloroquine derivative or a crystal form, pharmaceutically acceptable salt, hydrate or solvate thereof. The compound can be used for treating and/or preventing virus-related diseases, inflammatory diseases or inflammation-related diseases including autoimmune diseases, degenerative diseases, metabolic diseases, cardiovascular diseases, chronic infections, malignant diseases and the like. The deuterated hydroxychloroquine derivative has the advantages of high safety, relatively increased active metabolite, no activity, relatively reduced toxic and side effect metabolite and better pharmacodynamic/pharmacokinetic properties, and can be used as a medicinal effectivecomponent to form a medicinal composition, thereby enhancing the curative effect of the medicament and reducing the toxic and side effects of the medicament.

Novel intermediate for synthesizing teprenone and application of novel intermediate

The invention discloses a novel intermediate for synthesizing teprenone. The novel intermediate is a compound shown as a formula 5. The novel intermediate has the advantages that process routes for synthesizing the teprenone by the compound shown as the formula 5 are simple, raw materials are easily available, reaction conditions are mild, side reaction rarely can be carried out, and accordingly the novel intermediate is favorable for industrial production; the high-purity teprenone can be obtained by the aid of the process routes without rectification, and the requirements on ratios of isomermono-cis-form (5Z, 9E and 13E) to all-trans-forms (5E, 9E and 13E) of the teprenone can be met.